Conshohocken, PA, United States of America

Salvacion Cacatian

This inventor holds 33 USPTO granted patents and 13 published patent applications, plus 3 CIPO patents and 14 EPO patents, primarily in Cancer Therapeutics. Top assignees: Vitae Pharmaceuticals, Inc., Boehringer Ingelheim International Gmbh, Syndax Pharmaceuticals, Inc.. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Salvacion Cacatian. Retrieved from https://idiyas.com/inventor/salvacion-cacatian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 13)

% Patents Active = 54.5

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 14 (Patent Applications = 19)

Average Co-Inventor Count = 11.5

ph-index = 5

Forward Citations = 122(Granted Patents)

Location History:

Blue Bell, PA (US) (2010 - 2013)
West Conshohocken, PA (US) (2013)
Philadelphia, PA (US) (2010 - 2015)
Conshohocken, PA (US) (2013 - 2023)
Norristown, PA (US) (2024)

Company Filing History:

32 out of 85

Vitae Pharmaceuticals, Inc.

patents

8 out of 1,562

Boehringer Ingelheim International Gmbh

patents

1 out of 8

Syndax Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

Areas of Expertise:

Menin-MLL Interaction

CD73 Inhibitors

Beta-Secretase

Cyclic Urea

Hydroxysteroid Dehydrogenase

Renin Inhibitors

Aspartic Protease

Purine Derivatives

Piperidine

Cyclic Inhibitors

Diaminoalkane

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12312359 - Inhibitors of the menin-MLL interaction (2025-05-27),

2. 11919901 - Inhibitors of the menin-MLL interaction (2024-03-05),

3. 11739085 - Inhibitors of the menin-MLL interaction (2023-08-29),

4. 11479557 - Inhibitors of the menin-MLL interaction (2022-10-25),

5. 10899758 - Inhibitors of the menin-MLL interaction (2021-01-26),

6. 10683302 - Inhibitors of the menin-MLL interaction (2020-06-16),

7. 10654884 - Purine derivatives as CD73 inhibitors for the treatment of cancer (2020-05-19),

8. 10336717 - Inhibitors of beta-secretase (2019-07-02),

9. 9949975 - Inhibitors of beta-secretase (2018-04-24),

10. 9526727 - Inhibitors of beta-secretase (2016-12-27),

11. 9212153 - Inhibitors of beta-secretase (2015-12-15),

12. 9079861 - Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 (2015-07-14),

13. 9045500 - Inhibitors of beta-secretase (2015-06-02),

14. 9018391 - Inhibitors of beta-secretase (2015-04-28),

15. 8981112 - Inhibitors of β-secretase (2015-03-17),

Title: Inventor Salvacion Cacatian: Pioneering Innovations in Conshohocken

Introduction: Salvacion Cacatian is a trailblazing inventor based in Conshohocken, PA, known for her groundbreaking contributions to various fields.

Latest Patents: Salvacion Cacatian holds several patents in the areas of sustainable energy solutions, medical devices, and consumer electronics, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Salvacion Cacatian has worked with renowned research institutions and universities to develop cutting-edge technologies that have significantly impacted society.

Collaborations: Throughout her career, Salvacion Cacatian has collaborated with leading companies, innovative startups, and talented individuals to bring her inventions to life and make a lasting impact on the world.

Conclusion: Salvacion Cacatian's passion for innovation and dedication to creating meaningful change through her inventions have solidified her reputation as a pioneering inventor in Conshohocken and beyond.

Profile summary based on public USPTO records.